PRPF8 defects cause missplicing in myeloid malignancies

Leukemia

Volumn 29, Issue 1, 2015, Pages 126-136

  Kurtovic Kozaric, A ^a,h   Przychodzen, B ^a   Singh, J ^b   Konarska, M M ^c   Clemente, M J ^a   Otrock, Z K ^a   Nakashima, M ^b   Hsi, E D ^b   Yoshida, K ^d   Shiraishi, Y ^e   Chiba, K ^e   Tanaka, H ^e   Miyano, S ^e   Ogawa, S ^d,f   Boultwood, J ^g   Makishima, H ^a   Maciejewski, J P ^a   Padgett, R A ^b  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d GRADUATE SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f KYOTO UNIVERSITY   (Japan)

^g JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^h UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; PROTEIN DERIVATIVE; PRPF8 PROTEIN; UNCLASSIFIED DRUG; PRPF8 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW CELL; CANCER PROGNOSIS; CLINICAL ARTICLE; GENE MUTATION; HUMAN; HUMAN CELL; K562 CELL LINE; MUTANT; MYELOBLAST; NONHUMAN; PRIMARY CELL; RNA SEQUENCE; RNA SPLICING; YEAST; AMINO ACID SEQUENCE; CELL PROLIFERATION; CHEMISTRY; GENE DELETION; GENE SILENCING; GENETICS; HEMATOLOGIC DISEASE; HIGH THROUGHPUT SEQUENCING; MOLECULAR GENETICS; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; CELL PROLIFERATION; GENE DELETION; GENE KNOCKDOWN TECHNIQUES; HEMATOLOGIC NEOPLASMS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MOLECULAR SEQUENCE DATA; REAL-TIME POLYMERASE CHAIN REACTION; RNA SPLICING; RNA-BINDING PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84920675692     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2014.144     Document Type: Article

References (52)

1. Ley TJ, Mardis ER, Ding L, Fulton B, McLellan MD, Chen K et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 2008; 456: 66-72.
2. Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013; 368: 2059-2074.
3. Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 2011; 478: 64-69.
4. Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med 2011; 365: 1384-1395.
5. Haferlach T, Nagata Y, Grossmann V, Okuno Y, Bacher U, Nagae G et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia 2013; 28: 241-247.
6. Walter MJ, Shen D, Shao J, Ding L, White BS, Kandoth C et al. Clonal diversity of recurrently mutated genes in myelodysplastic syndromes. Leukemia 2013; 27: 1275-1282.
7. Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med 2010; 363: 2424-2433.
8. Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Masse A et al. Mutation in TET2 in myeloid cancers. N Engl J Med 2009; 360: 2289-2301.
9. Ernst T, Chase AJ, Score J, Hidalgo-Curtis CE, Bryant C, Jones AV et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat Genet 2010; 42: 722-726.
10. Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009; 361: 1058-1066.
11. Makishima H, Jankowska AM, Tiu RV, Szpurka H, Sugimoto Y, Hu Z et al. Novel homo-and hemizygous mutations in EZH2 in myeloid malignancies. Leukemia 2010; 24: 1799-1804.
12. Damm F, Itzykson R, Kosmider O, Droin N, Renneville A, Chesnais V et al. SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomo-nocytic leukemia and secondary acute myeloid leukemias. Leukemia 2013; 27: 1401-1403.
13. Makishima H, Yoshida K, Nguyen N, Przychodzen B, Sanada M, Okuno Y et al. Somatic SETBP1 mutations in myeloid malignancies. Nat Genet 2013; 45: 942-946.
14. Gomez-Segui I, Makishima H, Jerez A, Yoshida K, Przychodzen B, Miyano S et al. Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies. Leukemia 2013; 27: 1943-1946.
15. Visconte V, Makishima H, Jankowska A, Szpurka H, Traina F, Jerez A et al. SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts. Leukemia 2012; 26: 542-545.
16. Makishima H, Visconte V, Sakaguchi H, Jankowska AM, Abu Kar S, Jerez A et al. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood 2012; 119: 3203-3210.
17. Damm F, Kosmider O, Gelsi-Boyer V, Renneville A, Carbuccia N, Hidalgo-Curtis C et al. Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes. Blood 2012; 119: 3211-3218.
18. Hoskins AA, Moore MJ. The spliceosome: a flexible, reversible macromolecular machine. Trends Biochem Sci 2012; 37: 179-188.
19. Maciejewski JP, Padgett RA. Defects in spliceosomal machinery: a new pathway of leukaemogenesis. Br J Haematol 2012; 158: 165-173.
20. Grainger RJ, Beggs JD. Prp8 protein: at the heart of the spliceosome. RNA 2005; 11: 533-557.
21. Galej WP, Oubridge C, Newman AJ, Nagai K. Crystal structure of Prp8 reveals active site cavity of the spliceosome. Nature 2013; 493: 638-643.
22. Konforti BB, Konarska MM. U4/U5/U6 snRNP recognizes the 5' splice site in the absence of U2 snRNP. Genes Dev 1994; 8: 1962-1973.
23. Luo HR, Moreau GA, Levin N, Moore MJ. The human Prp8 protein is a component of both U2-and U12-dependent spliceosomes. RNA 1999; 5: 893-908.
24. Schellenberg MJ, Wu T, Ritchie DB, Fica S, Staley JP, Atta KA et al. A conforma-tional switch in PRP8 mediates metal ion coordination that promotes pre-mRNA exon ligation. Nat Struct Mol Biol 2013; 20: 728-734.
25. McKie AB, McHale JC, Keen TJ, Tarttelin EE, Goliath R, van Lith-Verhoeven JJ et al. Mutations in the pre-mRNA splicing factor gene PRPC8 in autosomal dominant retinitis pigmentosa (RP13). Hum Mol Genet 2001; 10: 1555-1562.
26. Towns KV, Kipioti A, Long V, McKibbin M, Maubaret C, Vaclavik V et al. Prognosis for splicing factor PRPF8 retinitis pigmentosa, novel mutations and correlation between human and yeast phenotypes. Hum Mutat 2010; 31: E1361-E1376.
27. Shaffer LG, Tommerup N. ISCN 2009. An International System for Human Cytogenetics Nomenclature. Karger: Basel, 2009.
28. Przychodzen B, Jerez A, Guinta K, Sekeres MA, Padgett R, Maciejewski JP et al. Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms. Blood 2013; 122: 999-1006.
29. Makishima H, Jankowska AM, McDevitt MA, O'Keefe C, Dujardin S, Cazzolli H et al. CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia. Blood 2011; 117: e198-e206.
30. Khan SN, Jankowska AM, Mahfouz R, Dunbar AJ, Sugimoto Y, Hosono N et al. Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies. Leukemia 2013; 27: 1301-1309.
31. Lesser CF, Guthrie C. Mutational analysis of pre-mRNA splicing in Saccharomyces cerevisiae using a sensitive new reporter gene, CUP1. Genetics 1993; 133: 851-863.
32. Query CC, Konarska MM. Suppression of multiple substrate mutations by spli-ceosomal Prp8 alleles suggests functional correlations with ribosomal ambiguity mutants. Mol Cell 2004; 14: 343-354.
33. Yeo G, Burge CB. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol 2004; 11: 377-394.
34. Liu L, Query CC, Konarska MM. Opposing classes of Prp8 alleles modulate the transition between the catalytic steps of pre-mRNA splicing. Nat Struct Mol Biol 2007; 14: 519-526.
35. Keightley MC, Crowhurst MO, Layton JE, Beilharz T, Markmiller S, Varma S et al. In vivo mutation of pre-mRNA processing factor 8 (Prpf8) affects transcript splicing, cell survival and myeloid differentiation. FEBS Lett 2013; 587: 2150-2157.
36. Visconte V, Makishima H, Maciejewski JP, Tiu RV. Emerging roles of the spliceo-somal machinery in myelodysplastic syndromes and other hematological disorders. Leukemia 2012; 26: 2447-2454.
37. Soenen V, Preudhomme C, Roumier C, Daudignon A, Lai JL, Fenaux P. 17p Deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ. Blood 1998; 91: 1008-1015.
38. Allende-Vega N, Dayal S, Agarwala U, Sparks A, Bourdon JC, Saville MK. p53 is activated in response to disruption of the pre-mRNA splicing machinery. Onco-gene 2012; 32: 1-14.
39. Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, Ong SE et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell 2008; 134: 112-123.
40. McKenzie M, Tucker EJ, Compton AG, Lazarou M, George C, Thorburn DR et al. Mutations in the gene encoding C8orf38 block complex I assembly by inhibiting production of the mitochondria-encoded subunit ND1. J Mol Biol 2011; 414: 413-426.
41. Yoshikumi Y, Mashima H, Ueda N, Ohno H, Suzuki J, Tanaka S et al. Roles of CTPL/Sfxn3 and Sfxn family members in pancreatic islet. J Cell Biochem 2005; 95: 1157-1168.
42. Ye X, Xu J, Cheng C, Yin G, Zeng L, Ji C et al. Isolation and characterization of a novel human putative anemia-related gene homologous to mouse sideroflexin. Biochem Genet 2003; 41: 119-125.
43. Lindhurst MJ, Fiermonte G, Song S, Struys E, De Leonardis F, Schwartzberg PL et al. Knockout of Slc25a19 causes mitochondrial thiamine pyrophosphate depletion, embryonic lethality, CNS malformations, and anemia. Proc Natl Acad Sci USA 2006; 103: 15927-15932.
44. Spiegel R, Shaag A, Edvardson S, Mandel H, Stepensky P, Shalev SA et al. SLC25A19 mutation as a cause of neuropathy and bilateral striatal necrosis. Ann Neurol 2009; 66: 419-424.
45. Badhai J, Frojmark AS, E JD, Schuster J, Dahl N. Ribosomal protein S19 and S24 insufficiency cause distinct cell cycle defects in Diamond-Blackfan anemia. Biochim Biophys Acta 2009; 1792: 1036-1042.
46. Boria I, Quarello P, Avondo F, Garelli E, Aspesi A, Carando A et al. A new database for ribosomal protein genes which are mutated in Diamond-Blackfan Anemia. Hum Mutat 2008; 29: E263-E270.
47. Collins CA, Guthrie C. Allele-specific genetic interactions between Prp8 and RNA active site residues suggest a function for Prp8 at the catalytic core of the spliceosome. Genes Dev 1999; 13: 1970-1982.
48. House AE, Lynch KW. Regulation of alternative splicing: more than just the ABCs. J Biol Chem 2008; 283: 1217-1221.
49. Umen JG, Guthrie C. A novel role for a U5 snRNP protein in 3' splice site selection. Genes Dev 1995; 9: 855-868.
50. Badhai J, Frojmark AS, Razzaghian HR, Davey E, Schuster J, Dahl N. Posttranscriptional down-regulation of small ribosomal subunit proteins correlates with reduction of 18S rRNA in RPS19 deficiency. FEBS Lett 2009; 583: 2049-2053.
51. Yang K, Zhang L, Xu T, Heroux A, Zhao R. Crystal structure of the beta-finger domain of Prp8 reveals analogy to ribosomal proteins. Proc Natl Acad Sci USA 2008; 105: 13817-13822.
52. Hahn D, Kudla G, Tollervey D, Beggs JD. Brr2p-mediated conformational rearrangements in the spliceosome during activation and substrate repositioning. Genes Dev 2012; 26: 2408-2421.